Compile Data Set for Download or QSAR
maximum 50k data
Found 35 Enz. Inhib. hit(s) with all data for entry = 6320
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123070(US8742115, 9)
Affinity DataKi:  0.900nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123096(US10213421, Example 10 | US11612596, Example 10. |...)
Affinity DataKi:  1.70nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123082(US10213421, Example 8 | US11612596, Example 8. | U...)
Affinity DataKi:  2.30nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123092(US8742115, 32)
Affinity DataKi:  2.30nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123072(US10213421, Example 2 | US11612596, Example 2. | U...)
Affinity DataKi:  3.20nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123076(US10213421, Example 3 | US11612596, Example 3. | U...)
Affinity DataKi:  3.5nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123080(US10213421, Example 6 | US11612596, Example 6. | U...)
Affinity DataKi:  4nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123089(US8742115, 29)
Affinity DataKi:  4.10nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123083(US10213421, Example 9 | US11612596, Example 9. | U...)
Affinity DataKi:  4.20nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123078(US10213421, Example 4 | US11612596, Example 4. | U...)
Affinity DataKi:  4.30nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123079(US10213421, Example 5 | US11612596, Example 5. | U...)
Affinity DataKi:  4.60nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123073(US8742115, 12)
Affinity DataKi:  4.70nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123081(US10213421, Example 7 | US11612596, Example 7. | U...)
Affinity DataKi:  5.20nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123084(US8742115, 24)
Affinity DataKi:  5.80nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123071(US8742115, 10)
Affinity DataKi:  6nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123077(US8742115, 16)
Affinity DataKi:  6.80nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123094(US8742115, 34)
Affinity DataKi:  7.90nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123093(US8742115, 33)
Affinity DataKi:  7.90nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123085(US8742115, 25)
Affinity DataKi:  8.30nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123069(US8742115, 8)
Affinity DataKi:  8.5nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123068(US10213421, Example 1 | US11612596, Example 1. | U...)
Affinity DataKi:  10.4nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123088(US8742115, 28)
Affinity DataKi:  17.8nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123074(US8742115, 13)
Affinity DataKi:  19.1nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123062(US8742115, 1)
Affinity DataKi:  23.4nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123064(US8742115, 3)
Affinity DataKi:  46.5nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123095(US8742115, 35)
Affinity DataKi:  61.3nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123065(US8742115, 4)
Affinity DataKi:  67.5nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123063(US8742115, 2)
Affinity DataKi:  69.6nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123090(US8742115, 30)
Affinity DataKi:  70.3nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123067(US8742115, 6)
Affinity DataKi:  72nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123091(US8742115, 31)
Affinity DataKi:  87.2nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123066(US8742115, 5)
Affinity DataKi:  197nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123086(US8742115, 26)
Affinity DataKi:  232nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123087(US8742115, 27)
Affinity DataKi:  414nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetC-C chemokine receptor type 3(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM123075(US8742115, 14)
Affinity DataKi:  1.40E+3nMAssay Description:The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxi...More data for this Ligand-Target Pair
In DepthDetails US Patent